Forte Biosciences, Inc.FBRXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-53.44M
↓ 83% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-29.14M
Historical baseline
PeriodValueYoY Change
TTM$-53.44M-46.0%
2024$-36.60M-12.7%
2023$-32.49M-133.8%
2022$-13.90M+35.3%
2021$-21.49M-51.0%
2020$-14.22M-250.0%
2019$-4.06M+91.1%
2018$-45.85M-21.9%
2017$-37.63M-18.7%
2016$-31.69M-